2431 - 2440 of 6564 Results
Title
Year
-
OPENTitle: Bioinspired Theranostic Coordination Polymer Nanoparticles for Intranasal Dopamine Replacement in Parkinson’s DiseaseJournal Name: ACS NanoPublisher: American Chemical Society (ACS)Vol: 15Issue #: 5Start Page: 8592End Page: 8609Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acsnano.1c00453Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acsnano.1c00453Citation Count: 101
-
OPENTitle: Synapsin III gene silencing redeems alpha-synuclein transgenic mice from Parkinson's disease-like phenotypeJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 30Issue #: 4Start Page: 1465End Page: 1483Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.ymthe.2022.01.021Best OA location URL: http://www.cell.com/article/S1525001622000211/pdfCitation Count: 25
-
OPENTitle: International Genetic Testing and Counseling Practices for Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 8Start Page: 1527End Page: 1535Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.29442Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10461455/pdf/nihms-1897358.pdfCitation Count: 16
-
OPENTitle: The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson’s diseaseJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page: 161End Page: 161Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-017-0456-2Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-017-0456-2Citation Count: 100
-
OPENTitle: Site-specific neuronal and motor effects of short-term intermittent burst deep brain stimulation in non-human primatesJournal Name: Brain StimulationPublisher: Elsevier BVVol: 18Issue #: 4Start Page: 1082End Page: 1084Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1016/j.brs.2025.05.009Best OA location URL: https://www.brainstimjrnl.com/action/showPdf?pii=S1935861X25001135Citation Count: 1
-
OPENTitle: OFF episode quality of life impact scale (OFFELIA): A new measure of quality of life for off episodes in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 123Issue #:Start Page: 106070End Page: 106070Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.106070Best OA location URL: http://www.prd-journal.com/article/S1353802024000828/pdfCitation Count: 3
- Risk of Parkinson's disease dementia related to level I MDS PD‐MCI2019OPENTitle: Risk of Parkinson's disease dementia related to level I MDS PD‐MCIJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 3Start Page: 430End Page: 435Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27617Citation Count: 65
-
OPENTitle: Protein Phosphatase 2A and Its Methylation Modulating Enzymes LCMT-1 and PME-1 Are Dysregulated in Tauopathies of Progressive Supranuclear Palsy and Alzheimer DiseaseJournal Name: Journal of Neuropathology & Experimental NeurologyPublisher: Oxford University Press (OUP)Vol: 77Issue #: 2Start Page: 139End Page: 148Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/jnen/nlx110Best OA location URL: https://academic.oup.com/jnen/article-pdf/77/2/139/23373432/nlx110.pdfCitation Count: 50
-
OPENTitle: Distinct brain atrophy progression subtypes underlie phenoconversion in isolated REM sleep behaviour disorderJournal Name: eBioMedicinePublisher: Elsevier BVVol: 117Issue #:Start Page: 105753End Page: 105753Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.ebiom.2025.105753Best OA location URL: https://www.thelancet.com/action/showPdf?pii=S2352396425001975Citation Count: 15
-
OPENTitle: Partial ablation of the orexin field induces a sub-narcoleptic phenotype in a conditional mouse model of orexin neurodegenerationJournal Name: SleepPublisher: Oxford University Press (OUP)Vol: 41Issue #: 9Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/sleep/zsy116Best OA location URL: https://academic.oup.com/sleep/article-pdf/41/9/zsy116/25714846/zsy116.pdfCitation Count: 13